PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$1,080
+64.6%
20,722
+100.0%
0.00%0.0%
Q2 2023$656
+16.9%
10,3610.0%0.00%0.0%
Q1 2023$561
+2.4%
10,3610.0%0.00%0.0%
Q4 2022$548
-99.9%
10,3610.0%0.00%0.0%
Q3 2022$482,000
-18.4%
10,3610.0%0.00%0.0%
Q2 2022$591,000
-6.8%
10,3610.0%0.00%0.0%
Q1 2022$634,000
+17.0%
10,3610.0%0.00%
+50.0%
Q4 2021$542,000
+40.4%
10,3610.0%0.00%0.0%
Q3 2021$386,000
-8.7%
10,3610.0%0.00%0.0%
Q2 2021$423,000
+20.2%
10,3610.0%0.00%0.0%
Q1 2021$352,000
+7.0%
10,3610.0%0.00%0.0%
Q4 2020$329,000
+23.7%
10,3610.0%0.00%
+100.0%
Q3 2020$266,0000.0%10,3610.0%0.00%
-50.0%
Q2 2020$266,000
+67.3%
10,3610.0%0.00%
+100.0%
Q1 2020$159,000
-18.5%
10,361
+82.2%
0.00%0.0%
Q4 2019$195,000
+364.3%
5,6870.0%0.00%
Q3 2019$42,000
-43.2%
5,6870.0%0.00%
Q2 2019$74,000
+7.2%
5,6870.0%0.00%
Q1 2019$69,000
+6.2%
5,6870.0%0.00%
Q4 2018$65,000
-47.2%
5,6870.0%0.00%
-100.0%
Q3 2018$123,000
+179.5%
5,687
+127.8%
0.00%
Q2 2018$44,000
-17.0%
2,4970.0%0.00%
Q1 2018$53,000
+47.2%
2,4970.0%0.00%
Q4 2017$36,0002,4970.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders